Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
SUMATRIPTAN , GLYCERYL TRINITRATE , RIMEGEPANT
The George Institute
Migraine
1 trial -
Sarilumab
Regeneron UK Limited
Rheumatoid Arthritis
8 trials -
Sarilumab
Regeneron UK Limited
Polymyalgia Rheumatica
1 trial -
Sertraline
United Therapeutics Europe Ltd
Generalised Anxiety Disorder
1 trial -
Sevelamer
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Degenerative Heart Valve Disease
1 trial -
Sevoflurane
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intra-abdominal and Intrapelvic Surgery
1 trial -
Sevoflurane
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Middle Aged Patients
1 trial -
Sitagliptin 50mg Film-coated Tablets, Trajenta 5 mg film-coated tablets, Pioglitazone Mylan 15 mg compresse, Ozempic 0.5 mg solution for injection in pre-filled pen, Jardiance 10 mg film-coated tablets, GLUCOPHAGE 1000 mg potahované tablety, Invokana 100 mg film-coated tablets, Trulicity 1.5 mg solution for injection in pre-filled pen, Galvus 50 mg tablets, Forxiga 10 mg film-coated tablets
The George Institute
Type 2 Diabetes Mellitus
1 trial -
Sodium Bicarbonate Ringer's Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Shock
1 trial -
Solriamfetol
Jazz Pharmaceuticals Ireland Limited
Binge Eating Disorder
1 trial -
Spesolimab
Boehringer Ingelheim
Generalized Pustular Psoriasis
3 trials -
Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine
Moderna Biotech Spain
SARS-CoV-2 infection
1 trial -
Spinraza 12 mg solution for injection
Biogen
Spinal Muscular Atrophy
1 trial -
Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
Subcutaneous depot medroxyprogesterone acetate
Protara Therapeutics
Contraception
1 trial -
Sugammadex hameln 100 mg/ml oplossing voor injectie, Naloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuit, ANEXATE 0,5 mg/5 ml, solution injectable (I.V.), REMIMAZOLAM , Sufentanil Viatris 5 microgram/ml oplossing voor injectie, Esmeron 10 mg/ml, oplossing voor injectie
Disc Medicine
General anesthesia
1 trial -
Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.
The George Institute
Obesity
1 trial -
Surabgene Lomparvovec (ABBV-RGX-314), Lucentis 10 mg/ml solution for injection in pre-filled syringe, Surabgene Lomparvovec (ABBV-RGX-314)
AbbVie Deutschland GmbH & Co. KG
Neovascular age-related macular degeneration
1 trial -
TACROLIMUS, SIROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, PREDNISOLONE, EVEROLIMUS, MYCOPHENOLIC ACID, BELATACEPT, CICLOSPORIN
The George Institute
BK Polyomavirus DNAemia after kidney transplantation
1 trial -
TESTOGEL 50 mg gel transdérmico en sobres, Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, Bemfola 300 IU/0.50 mL solution for injection in pre-filled pen, Astarté 0,25 mg/0,5 ml solución inyectable en jeringa precargada EFG
The George Institute
low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism
1 trial -
TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.
LEO Pharma A/S
Atopic dermatitis and moderate-to severe atopic hand eczema
1 trial -
TRANEXAMIC ACID
The George Institute
Hip fracture
1 trial -
Telavancin
Theravance Biopharma Ireland Umited
End-Stage Renal Disease
1 trial -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Subarachnoid Hemorrhage, Aneurysmal
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources